Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-013975
Filing Date
2024-12-18
Accepted
2024-12-18 14:36:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27692
2 filename2.txt TEXT-EXTRACT 1192
  Complete submission text file 0000000000-24-013975.txt   40102
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filed for) CIK: 0001806310 (see all company filings)

EIN.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-283801
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)